
Keywords: aAPC; artificial APC; ACT; adoptive cell therapy; CDM; chemically defined media; cGMP; current Good Manufacturing Practices; DC; dendritic cell; CPP; critical process parameter; CQA; critical quality attribute; FACS; fluorescence activated cell sorting; H